VIVUS to Extend Return Date of STENDRA Commercial Rights
MOUNTAIN VIEW, CA--(Marketwired - June 30, 2016) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, …